Phase III

Sofpromed provides full clinical trial management services for phase III studies in oncology across Europe and worldwide.

The drugs that progress to phase III trials are definitively assessed for effectiveness in the treatment of tumors. These types of trials are more complex than those in other phases, as these studies require more time to be completed and are larger in size (typically 300+ patients).

Our phase III capabilities include regulatory affairs, site selection and activation, site management, clinical monitoring, data management, logistics management, drug safety, biostatistics, medical writing, and project management.

 ← Pashe II                   Late Phase → 

Subscribe To Our Articles and Updates


You have Successfully Subscribed!